Drag a card by its title · ⚙ to size, swap or remove

The company

Kura Oncology, Inc.

KURA · Nasdaq

Health CareBiotechnologyJust dropped out

KURA stood above a rising 150-day average in 23 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 10.6% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Just dropped out
Weeks in an uptrend: out for 1
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $4.7M
Insider sales, 12 months: $6.8M
Officials’ trades on record: 1
Institutions holding: 206 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 23 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 1, Senate 0, executive 0; 1 people.

Who	Did	Amount	Traded
Chris Jacobs House: U.S. House ClerkNY27	bought	$1k–$15k	12 Dec 2022filed 20 Jan 2023

Insiders

Buy orders, 12 months2

Sale orders, 12 months29

Buyers · sellers1 · 7

Who	Did	Shares	Traded
Brian T. PowlChief Commercial Officer	sold	15,430at $10.75	29 Sep 2026filed 29 Sep 2026
Mollie LeoniChief Medical Officer	sold	28,802at $10.75	29 Sep 2026filed 29 Sep 2026
Kathleen FordChief Operating Officer	sold	3,668at $10.75	29 Sep 2026filed 29 Sep 2026
Brian T. PowlChief Commercial Officer	sold	9,020at $10.50	28 Sep 2026filed 29 Sep 2026
Brian T. PowlChief Commercial Officer	sold	8,000at $10.56	28 Sep 2026filed 29 Sep 2026
Thomas James DoyleSVP, Finance & Accounting	sold	4,607at $10.50	28 Sep 2026filed 29 Sep 2026
Mollie LeoniChief Medical Officer	sold	12,448at $10.50	28 Sep 2026filed 29 Sep 2026
Kathleen FordChief Operating Officer	sold	6,906at $10.50	28 Sep 2026filed 29 Sep 2026
Teresa Brophy BairChief Legal Officer	sold	8,442at $10.50	28 Sep 2026filed 29 Sep 2026
Francis BurrowsChief Scientific Officer	sold	20,726at $10.83	24 Sep 2026filed 25 Sep 2026
Troy Edward WilsonPresident and CEO	bought	100,000at $12.39	24 Aug 2026filed 24 Aug 2026
Brian T. PowlChief Commercial Officer	sold	4,345at $11.89	21 Aug 2026filed 24 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders206+2 on the quarter

New · exited29 · 27

Reported value$951.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	10,509,233$115.3M	+871,702+9.0%
MONTANOVA CAPITAL, LLCunchanged · filed 14 Aug 2026	8,575,422$94.1M	00.0%
BVF INCunchanged · filed 14 Aug 2026	8,445,769$92.7M	00.0%
STATE STREET CORPadded · filed 7 Aug 2026	5,329,208$58.5M	+817,317+18.1%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	3,916,164$43.0M	+130,479+3.4%
ARMISTICE CAPITAL, LLCreduced · filed 14 Aug 2026	3,678,000$40.3M	-58,000−1.6%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026	3,126,727$34.3M	+1,002,247+47.2%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026	2,265,171$24.8M	+831,700+58.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	2,229,958$24.5M	+195,682+9.6%
ALETHEA CAPITAL MANAGEMENT, LLCadded · filed 14 Aug 2026	2,167,938$23.8M	+638,569+41.8%